Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD
Go back to Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD| (NASDAQ: PULM) | Delayed: 1.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.40 | 52 Week High | $5.56 | |||
| Open | $1.40 | 52 Week Low | $0.76 | |||
| Day High | $1.40 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $0.00 | |||
| Volume | 1 | |||||
